AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitabac M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Bacans Biotech Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitabac M 50mg/500mg Tablet

Diabex Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabex Duo may be used independently or in conjunction with other diabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and current medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your physician's guidance. Adherence to your prescribed diet and exercise plan is crucial for diabetes control, as lifestyle significantly impacts management. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and sore throat. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; learn to recognize and manage this. This medication is not universally suitable. Inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption before use. Pregnant or lactating individuals should seek medical advice prior to use. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol consumption should be minimized due to its potential to lower blood sugar. Your doctor will monitor your kidney function and blood glucose levels throughout treatment.

Uses of Sitabac M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitabac M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Sitabac M 50mg/500mg Tablet should be administered with a meal.

Common Side effects of Sitabac M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitabac M 50mg/500mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitabac M 50mg/500mg tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Sitabac M 50mg/500mg Tablet works:

Sitagliptin and metformin, combined as Sitabac M 50mg/500mg tablets, work synergistically to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitabac M 50mg/500mg Tablet with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitabac M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Sitabac M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitabac M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. The medication is contraindicated for those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Use of Sitabac M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Seek medical advice.

What if you forget to take Sitabac M 50mg/500mg Tablet :

Should you forget a Sitabac M 50mg/500mg Tablet dose, administer it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitabac M 50mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Sitabac M 50mg/500mg Tablet

Sitagliptin and Metformin, combined as Sitabac M 50mg/500mg Tablet, treat type 2 diabetes mellitus. This medication enhances blood sugar control in adults when coupled with a healthy diet and regular physical activity. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin's action involves DPP4 enzyme inhibition, stimulating increased insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Prolonged use of Sitabac M 50mg/500mg tablets can indeed lead to Vitamin B12 deficiency. This medication impairs the body's ability to absorb Vitamin B12 from the digestive system. Untreated deficiency can result in anemia and neurological complications, manifesting as numbness and tingling in the extremities, muscle weakness, bladder dysfunction, cognitive changes, and impaired coordination. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, has been proposed by some studies.
Sitabac M 50mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitabac M 50mg/500mg Tablet constituent or inactive ingredient should not take this medication. Similarly, its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabac M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of developing lactic acidosis.
Store the medication in its original, tightly sealed container or packaging, following the storage guidelines provided on the label. Discard any remaining medication. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of taking Sitabac M 50mg/500mg tablets. This complication, also termed Metformin-associated lactic acidosis (MALA), is uncommon but necessitates caution. Consequently, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, or those consuming significant alcohol. Manifestations of lactic acidosis can include muscular discomfort or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal pain, and bradycardia. Should these symptoms arise, discontinue Sitagliptin + Metformin immediately and seek urgent medical attention.
Sitagliptin and Metformin, combined as Sitabac M 50mg/500mg tablets, manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin's action involves DPP4 enzyme inhibition, stimulating pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitabac M 50mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitabac M 50mg/500mg Tablet constituents or inactive ingredients should not use this medication. Similarly, its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabac M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of developing lactic acidosis.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential side effect of Sitabac M 50mg/500mg Tablet. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution. Consequently, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, or those with significant alcohol consumption. Symptoms such as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia should prompt immediate cessation of Sitagliptin + Metformin and immediate medical attention.
Prolonged use of Sitabac M 50mg/500mg tablets can indeed lead to vitamin B12 deficiency. This medication impedes the stomach's absorption of vitamin B12. Consequently, untreated deficiency may result in anemia and neurological complications, manifesting as tingling or numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, supplemental vitamin B12 intake, at least annually, is recommended by some studies.
Retain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Sitagliptin and Metformin, combined as Sitabac M 50mg/500mg Tablet, treat type 2 diabetes mellitus. This medication improves blood sugar control in adults when used with a healthy diet and regular physical activity. Metformin reduces liver glucose production and enhances insulin sensitivity. Sitagliptin works by blocking DPP4, thus boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitabac M 50mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitabac M 50mg/500mg Tablet ingredient or excipient should not use this medication. Its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitabac M 50mg/500mg Tablet is unsafe due to a heightened risk of lactic acidosis.
Sitabac M 50mg/500mg Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse reaction necessitates caution in patients with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms can manifest as muscle pain/weakness, dizziness, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal discomfort, or bradycardia. If these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Indeed, prolonged use of Sitabac M 50mg/500mg tablets can lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption in the gastrointestinal tract. Consequently, untreated deficiency may result in anemia and neurological complications, potentially manifesting as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, according to some studies, include annual supplemental Vitamin B12 intake.
Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitabac M 50mg/500mg Tabl...
95
MRP 110
13% off